NUDT5 as a novel target for ovarian cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210354
- Recipient
-
University Of California, LOS Angeles UEI RN64EPNH8JC6 Part of State Of California Controllers Office
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $662,086
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Los Angeles, CA 90024, USA
Award details come from USAspending.gov.
About this award
The University of California, Los Angeles (UCLA) was awarded a $662,086 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2022 to April 30, 2025 to investigate NUDT5 as a novel target for ovarian cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of transforming health care for service members and the public through innovative medical solutions applicable both to the battlefield and civilian settings. UCLA will utilize the funding to conduct research that could provide new treatment options for ovarian cancer.
Quick answers
Who received award W81XWH2210354?
W81XWH2210354 was awarded to University Of California, LOS Angeles by Medical Command (Department of the Army) on May 1, 2022.
How much is award W81XWH2210354 worth?
$662,086 has been obligated on W81XWH2210354.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award